MedPath

Nystatin

NYSTATIN ORAL SUSPENSION, USP

Approved
Approval ID

ceb0fc2d-9039-4961-84b6-ceb2a2649c50

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nystatin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42254-067
Application NumberANDA062512
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nystatin
Product Specifications
Route of AdministrationORAL
Effective DateJune 28, 2010
FDA Product Classification

INGREDIENTS (12)

NystatinActive
Quantity: 100000 [USP'U] in 1 mL
Code: BDF1O1C72E
Classification: ACTIB
waterInactive
Code: 059QF0KO0R
Classification: IACT
sucroseInactive
Code: C151H8M554
Classification: IACT
glycerinInactive
Code: PDC6A3C0OX
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
magnesium aluminum silicateInactive
Code: 6M3P64V0NC
Classification: IACT
alcoholInactive
Code: 3K9958V90M
Classification: IACT
propylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
potassium phosphate, dibasicInactive
Code: CI71S98N1Z
Classification: IACT
methylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
D&C yellow no. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C red no. 40Inactive
Code: WZB9127XOA
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.